Guardian Pharmacy Services, Inc. $GRDN Stock Position Lowered by Sterling Capital Management LLC

Sterling Capital Management LLC trimmed its holdings in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) by 94.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,054 shares of the company’s stock after selling 19,267 shares during the quarter. Sterling Capital Management LLC’s holdings in Guardian Pharmacy Services were worth $43,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Jennison Associates LLC increased its holdings in Guardian Pharmacy Services by 609.5% in the 1st quarter. Jennison Associates LLC now owns 822,784 shares of the company’s stock worth $30,986,000 after acquiring an additional 706,823 shares in the last quarter. Sei Investments Co. raised its position in Guardian Pharmacy Services by 40.5% during the first quarter. Sei Investments Co. now owns 358,181 shares of the company’s stock worth $13,489,000 after acquiring an additional 103,177 shares during the period. Braun Stacey Associates Inc. acquired a new position in Guardian Pharmacy Services during the second quarter worth $14,234,000. Dimensional Fund Advisors LP lifted its holdings in Guardian Pharmacy Services by 200.0% during the first quarter. Dimensional Fund Advisors LP now owns 208,594 shares of the company’s stock valued at $7,855,000 after purchasing an additional 139,070 shares in the last quarter. Finally, Ranger Investment Management L.P. purchased a new position in Guardian Pharmacy Services during the second quarter valued at $7,263,000.

Analysts Set New Price Targets

Several analysts have recently issued reports on the stock. Oppenheimer lifted their target price on shares of Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an “outperform” rating in a research report on Friday, August 7th. KeyCorp began coverage on shares of Guardian Pharmacy Services in a research report on Tuesday, September 22nd. They set an “overweight” rating and a $52.00 price target for the company. Wall Street Zen lowered shares of Guardian Pharmacy Services from a “buy” rating to a “hold” rating in a research note on Sunday, October 25th. Weiss Ratings lowered shares of Guardian Pharmacy Services from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, October 23rd. Finally, Truist Financial lifted their price objective on Guardian Pharmacy Services from $47.00 to $51.00 and gave the stock a “buy” rating in a report on Monday, September 21st. Nine investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $45.57.

Guardian Pharmacy Services Stock Performance

Shares of GRDN opened at $42.03 on Thursday. The stock has a 50 day moving average price of $41.28 and a 200 day moving average price of $38.17. Guardian Pharmacy Services, Inc. has a one year low of $26.34 and a one year high of $48.33. The stock has a market capitalization of $2.09 billion, a price-to-earnings ratio of 40.81, a PEG ratio of 2.13 and a beta of 0.06.

Guardian Pharmacy Services (NYSE:GRDN) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.29 earnings per share for the quarter, beating analysts’ consensus estimates of $0.26 by $0.03. Guardian Pharmacy Services had a return on equity of 29.97% and a net margin of 4.50%. The company had revenue of $351.77 million for the quarter, compared to analyst estimates of $340.45 million. On average, analysts predict that Guardian Pharmacy Services, Inc. will post 1.18 earnings per share for the current year.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc is a provider of pharmacy services focused primarily on residents of long-term care and other institutional healthcare settings. Through its network of pharmacies, the company supplies prescription medications and related pharmacy support to assisted living communities, skilled nursing facilities, behavioral health organizations, and other care providers.

The company’s services include medication dispensing and packaging, prescription delivery, medication management, clinical pharmacy support, and technology-enabled tools designed to help caregivers and healthcare professionals manage residents’ medication regimens.